Professional Documents
Culture Documents
10/03/2020
2
Some Facts About Schizophrenia
Schiz: “Split” with reality
Occurs in all cultures
Affects 1.5% of American population at
any one time, 10-15X more vulnerable
1/2 of psychiatric hospitalizations
M=F; more common in lower SES
(downward drift)
Blacks less severely impaired than whites;
females less severely impaired than males
Onset typically in late adolescence/early
adulthood
The “cancer of mental illness”
Types of Schizophrenia
Disorganized (hebephrenic) -- silly and
incoherent (most severe)
Catatonic -- grossly abnormal motor
behavior and negativism (least common)
Paranoid -- grossly delusional but better
prognosis (most common)
Undifferentiated -- All others
Residual -- After it’s all over
Predisposing factors
Combination of genetic and environmental factors
Neurobiological factors –imaging studies show
decreased brain volume (white matter). Findings
include atrophy in the frontal lobe, cerebellum and
limbic structures. There are also alterations in
neurotransmitters (dopamine, serotonin, and
glutamate)
Genetic Risk for Schizophrenia
Fraternal twin 50 % risk
Identical twin 15 % risk
Sibling 10 % risk
One parent affected 15% risk
Both parents affected 35% risk
No affected relative 1% risk
Zullies Ikawati's Lecture Notes 10/03/2020
7
A graph to show the genetic
risk of developing
schizophrenia.
Source: Zimbardo et al
(1995)
Information-processing overload
10/03/2020
17
1. Jalur nigrostriatal: dari substantia nigra ke basal ganglia fungsi gerakan,
EPS
2. jalur mesolimbik : dari tegmental area menuju ke sistem limbik memori,
sikap, kesadaran, proses stimulus
3. jalur mesocortical : dari tegmental area menuju ke frontal cortex kognisi,
fungsi sosial, komunikasi, respons terhadap stress
4. jalur tuberoinfendibular: dari hipotalamus ke kelenjar pituitary pelepasan
Zullies Ikawati's Lecture Notes 10/03/2020
19
-Basal Ganglia – involved in the movement of emotions and sensory info.
Abnormal function is thought to contribute to paranoia and hallicinations
-Frontal Lobe – critical to problem solving. Leads to difficulty planning
actions and organizing thoughts
-Limbic System – involved in emotion, contributes to agitation
-Auditory System - hear and understand speech. Overactivity in
Weirnickes area can cause auditory hallucinations.
-Occipital lobe – process info about visual world. Difficulties interpreting
complex images, recognizing motion and reading emotions on others.
-Hippocampus - learning and memory function – both severely impaired
by Chilhood Onset of Schizophrenia.
In human anatomy, the
extrapyramidal system is a neural
network located in the brain that is
part of the motor system involved
in the coordination of movement.
The system is called
"extrapyramidal" to distinguish it
from the tracts of the motor cortex
that reach their targets by traveling
through the "pyramids" of the
medulla.
The pyramidal pathways
(corticospinal and some
corticobulbar tracts) may directly
innervate motor neurons of the
spinal cord or brainstem (anterior
horn cells or certain cranial nerve
nuclei), whereas the
extrapyramidal system centers
around the modulation and
10/03/2020 21
regulation (indirect control) of
• serotonergic neurons from the dorsal and median raphe nuclei project to
dopaminergic cell bodies within the VTA and SN of the midbrain.
• Serotonergic neurons primarily from the dorsal raphe project to the terminal
fields of the striatum, nucleus accumbens, and cortex.
• Serotonergic neurons have been reported to directly terminate on dopaminergic
cell bodies and exert an inhibitory influence on mesolimbic and nigrostriatal
Zullies Ikawati's Lecture Notes 10/03/2020
dopamine activity through 5-HT2A receptors 22
reductions in serotonin activity are associated with
enhancements in dopamine activity
10/03/2020
23
lanjutan
10/03/2020
27
Diagnostic and Statistical Manual of Mental Disorders edisi 4 (DSM-IV) membagi
gejala skizoprenia menjadi 2 katagori berkembang menjadi 3 kategori (APA)
10/03/2020
30
Schizophrenia
Diagnostic Criteria for Schizophrenia (DSM-IV)
A. Characteristic symptoms: Two (or more) of the following, each prodromal or residual periods, the signs of the disturbance may be
present for a significant portion of time during a 1-month period manifested by only negative symptoms or two or more symptoms
(or less if successfully treated): listed in Criterion A present in an attenuated form (e.g., odd beliefs,
unusual perceptual experiences).
(1) delusions
(2) hallucinations D. Schizoaffective and Mood Disorder exclusion: Schizoaffective
(3) disorganized speech (e.g., frequent derailment or incoherence) Disorder and Mood Disorder With Psychotic Features have been
(4) grossly disorganized or catatonic behavior ruled out because either (1) no Major Depressive, Manic, or Mixed
(5) negative symptoms, i.e., affective flattening, alogia, or avolition Episodes have occurred concurrently with the active-phase
symptoms; or (2) if mood episodes have occurred during active-phase
B. Social/occupational dysfunction: For a significant portion of the symptoms, their total duration has been brief relative to the duration
time since the onset of the disturbance, one or more major areas of of the active and residual periods.
functioning such as work, interpersonal relations, or self-care are
markedly below the level achieved prior to the onset (or when the E. Substance/general medical condition exclusion: The disturbance is
onset is in childhood or adolescence, failure to achieve expected not due to the direct physiological effects of a substance (e.g., a drug
level of interpersonal, academic, or occupational achievement). of abuse, a medication) or a general medical condition.
C. Duration: Continuous signs of the disturbance persist for at least 6 F. Relationship to a Pervasive Developmental Disorder: If there is a
months. This 6-month period must include at least 1 month of history of Autistic Disorder or another Pervasive Developmental
symptoms (or less if successfully treated) that meet Criterion A (i.e., Disorder, the additional diagnosis of Schizophrenia is made only if
active-phase symptoms) and may include periods of prodromal or prominent delusions or hallucinations are also present for at least a
residual symptoms. During these month (or less if successfully treated).
American Psychiatric Association: Diagnostic and Manual of Mental Disorders, 4th ed, Text Revision
(DSM-IV-TR)
Prognosis
Prognosis cukup baik jika : onset lebih lambat,
pemicunya diketahui, sejarah pre-morbid bagus, dan ada
dukungan keluarga 20-30% mungkin bisa kembali
normal
Kurang lebih 20-30 % mungkin akan mengalami gejala
sedang
40 – 60% mungkin tidak akan kembali normal seumur
hidupnya
10/03/2020
32
Schizophrenia
Prognostic Features
Good Prognosis Poor Prognosis
Later onset Early onset
Obvious precipitating factors No precipitating factors
Acute onset Insidious onset
Good premorbid social and work history Poor premorbid social and work history
Preponderant positive symptoms Preponderant negative symptoms
Depressive symptoms Absence of depressive symptoms
Preservation of adequate affective expression Blunted or inappropriate affect
Paranoid or catatonic features Undifferentiated or disorganized features
Variable course Chronic course
Absence of neuropsychological impairment Presence of neuropsychological impairment
Absence of structural brain abnormalities Presence of structural brain abnormalities
Good social support systems Poor social support systems
Early adequate treatment No treatment or delayed/ inadequate treatment
Adapted from: Sadock BJ, Sadock VA: Kaplan and Sadock’s Comprehensive Textbook of Psychiatry, 7th ed, Philadelphia,
Lippincott Williams & Wilkins, p. 1197
Schizophrenia
Complications
Suicide – 5-10% of deaths
Depression - occurs in 50% of cases, often
after an acute episode
Homelessness – 30-35% of homeless
Crime: 4-fold increase in acts of violence
compared with the general population. These
patients are more frequently victims of both
violent and nonviolent crimes.
Substance abuse
Sasaran terapi
Sasaran terapi: bervariasi, berdasarkan fase
dan keparahan penyakit
Pada fase akut : mengurangi atau
menghilangkan gejala psikotik dan
meningkatkan fungsi
Pada fase stabilisasi: mengurangi resiko
kekambuhan dan meningkatkan adaptasi
pasien terhadap kehidupan dalam masyarakat
10/03/2020
35
Strategi terapi
Non-farmakologi :
program rehabilitasi : living skills, social skills,
10/03/2020
36
Non pharmacological treatment
Psychosocial interventions
Antipsikotik
Tipikal/FGA Atipikal/SGA
10/03/2020
42
Terapi stabilisasi
Terapi minggu ke 2-3 terapi stabilisasi tujuannya:
meningkatkan sosialisasi dan perbaikan kebiasaan (self-
care habits) dan perasaan
Mungkin perlu waktu 6-8 minggu utk mendapat respon
yang diharapkan, pada pasien kronis mungkin butuh
waktu 3-6 bulan
Pengobatan : menggunakan antipsikotik atipikal (if any);
jika menggunakan obat tipikal: dosis yang ekuivalen
dengan klorpromasin 300-1000 mg dapat digunakan
Terapi tidak bisa menyembuhkan, hanya mengurangi
gejala
10/03/2020
43
Terapi pemeliharaan
Tujuan : mencegah kekambuhan
harus diberikan sedikitnya sampai setahun sejak sembuh dari
episode akut
bahkan untuk bisa lebih berhasil perlu terapi selama
sedikitnya 5 tahun, kemudian dosis pada diturunkan perlahan-
lahan
terapi pemeliharaan dapat diberikan dalam dosis setengah dari
dosis akut
bagi pasien yang kepatuhannya rendah ada obat yang dibuat
dalam formulasi depot contoh : flufenazin dekanoat atau
haloperidol dekanoat dapat diberikan setiap 2 -4 minggu
sekali secara i.m. tetapi formulasi depot ini hanya dapat
diberikan jika pasien telah memiliki dosis efektif p.o yang
stabil
Recently : Risperidon long acting dg dosis 25-50 mg IM every
2 weeks Zullies Ikawati's Lecture Notes 10/03/2020
44
Penatalaksanaan pasien yang resisten
terhadap pengobatan
10/03/2020
45
TIMA
Algoritma terapi skizoprenia
Serangan pertama Tahap 1:
atau belum pernah Coba SGA tunggal:
menggunakan SGA max 12 minggu
Aripiprazol, olanzapin,
sebelumnya quetiapin, risperidon, atau
ziprasidon
Respon parsial atau tidak ada
Tahap 2:
Coba SGA tunggal yang lain max 12 minggu
selain yang dipakai pada tahap 1
Respon parsial atau tidak ada Respon parsial atau tidak ada
6 bulan
Tahap 2A Tahap 3
Coba FGA atau SGA yg lain Respon parsial Coba FGA atau SGA yg lain
atau tidak ada
10/03/2020
46
Respon parsial atau tidak ada
Tahap 4
Klozapin Menolak klozapin
Tahap 5
Coba satu obat
FGA atau
SGA
yg belum
tidak ada respon dicoba
Tahap 6
Terapi kombinasi
SGA + FGA, kombinasi SGA,
(FGA atau SGA) + ECT,
(FGA atau SGA) + agen lain
10/03/2020
47
Algoritma tatalaksana terapi
Tidak ada riwayat Ada riwayat
Kegagalan terapi AT Kegagalan terapi AT
Olanzapin or Gunakan Olanzapin or Gunakan
Stage 1 Quetiapin or salah satu Quetiapin or salah satu
Risperidon Risperidon
Tidak ada respon Tidak ada respon
Tidak Tidak
Stage 2 Gunakan yang lain patuh Haloperidol dekanoat Gunakan yang lain
atau flufenazin dekanoat patuh
Tidak ada respon Tidak ada respon
Tidak ada respon
Stage 3 Gunakan yang lain Gunakan yang lain
Gunakan yang lain
Tidak ada respon Tidak ada respon
Stage 4 Gunakan AP tipikal Tidak ada respon
Stage 5 Clozapin
Respon parsial
Stage 5b
Kombinasi Atipikal+tipikal, atau kombinasi tipikal,
atau kombinasi atipikal, atau atipikal + ECT
10/03/2020
49
Efek samping relatif
Obat sedasi ekstrapiramidal antikolinergi ortostatik
k
Klorpromaz ++++ +++ +++ ++++
in
Flufenazin + ++++ + +
Haloperidol + ++++ + +
Loksapin +++ +++ ++ +++
Perfenazin ++ +++ ++ ++
Tioridazin ++++ +++ ++++ ++++
Tiotiksen + ++++ + +
Molindon + +++ ++ ++
Klozapin ++++ ++++ ++++
Olanzapin ++ ++ ++ ++
Quetiapin ++ + + ++
Risperidon + ++ + ++
Zullies Ikawati's Lecture Notes 10/03/2020
Ziprasidon ++ ++ + ++ 50
Zullies Ikawati's Lecture Notes 10/03/2020
51
Rentang dosis oral efektif dan potensi anti psikotik
Obat Dosis akut Dosis pemeliharaan Potensi
(mg/hari) (mg/hari)
Klorpromasin 400 – 1000 100 – 300 100
Tioridazin 400 – 800 100 – 200 100
Flufenazin 10 – 60 3 – 20 2
Perfenazin 8 – 64 4 – 32 8
Trifluoperazin 20 – 80 5 – 20 5
Tiotiksen 20 – 80 5 – 30 4
Haloperidol 10 – 60 3 – 20 2
Loxapin 40 – 160 20 – 80 10
Molindon 50 – 200 20 – 100 10
Klozapin 300 – 600 150 – 400 -
Risperidon 4–6 2–4 -
Olanzapin 10 – 20 5 – 50 -
Quetiapin 300 – 600 150 – 300 -
Zullies Ikawati's Lecture Notes 10/03/2020
52
Antipsikotik yang beredar di Indonesia
(ISO 2004, IONI 2000)
10/03/2020
53
Masalah dalam penggunaan obat antipsikotik : ketidakpatuhan
akibat efek samping obat
10/03/2020
55
Zullies Ikawati's Lecture Notes 10/03/2020
56
Prevention ?
Recent study : schizophrenia is due to a genetic predisposition and
environmental stressors early in a child's development (during
pregnancy and birth, and/or early childhood) which lead to
subtle alterations in the brain that make a person susceptible to
developing schizophrenia.
Additional environmental factors and stresses later in life (during
childhood, adolescence and young adulthood) can either damage
the already vulnerable brain further or lessen the expression of
neurodevelopmental defects and decrease the risk of
schizophrenia
10/03/2020
58
Agranulocytosis Monitoring Guidelines
Check WBC before starting clozapine. Do not start the drug if the WBC
is less than 3500/mm3.
Teach patient to immediately report any sign of infection, such as sore
throat, fever, weakness, lethargy.
Measure WBC level every week during treatment and for 4 weeks after
treatment ends.